ace super jili

Time: 2025-01-10   Source: ace super jili    Author:how to win in jili super ace
ace super jili
ace super jili So once again the annual environmental circus that is a United Nations COP summit drew to a close last night and once again everyone involved blamed everyone else for the fact no-body was really happy with the 13th hour drop-in-the-ocean deal, despite the Azerbaijan host’s desperate efforts. Like the UN, one begins to wonder what the point of this oft-ridiculous political set-piece actually is. COP 29 in Azerbaijan was slated to end on Friday night - but because absolutely nothing had been achieved it ran over into an emergency session which ended with a cobbled-together deal nobody seems to want, in the early hours of this morning. The over-run was triggered by a group of small island states who walked out in disgust at the developed nations’ (read the West’s) inaction. “A bad deal is worse than no-deal” protesters in Baku had been earnestly chanting all week. But with a climate-sceptical Trump presidency just around the corner the small island negotiators knew that was just a slogan on a placard and, after securing headlines with the walkout, returned to the table and took the deal. And the deal was basically the rich nations pay the poor nations $300bn to help mitigate the effects of climate change. But, thanks in no small part to the ducking and weaving of a perennially unhelpful EU, it was proper chuck-a-dart-in-a-dartboard economics. The bidding started at $100bn. Then $250bn was mooted, and - thanks largely to the Azerbaijan hosts climate activists have been monstering all week - a figure of $300bn was eventually agreed. (One advocate even demanded $7 TRILLION, or about a fifth of all the money in the entire world. One wonders about the basic grasp of economics of some of our would-be leaders.) The British Government who, to their credit, seemed to be at the forefront of negotiations supporting Azerbaijan in the final hours, managed to find an extra chunk of small change - some £239m - even though no-one was asking. It will be spent by the UN tackling deforestation. Of course what our pensioners and farmers will make of that I shall leave to you to decide. There is a very confusing clause tacked on to the deal too, to raise a further $1.3tn from the private sector across the planet, though no-one seems to know quite how, except your airline tickets will be going up. Well of course they will. A ridiculously posturing China by the way was pushing for $500Bn to be given to the developing nations. But then she would. China is the planet's second richest economy - within a decade she will be the No1 global superpower and yet at COP (and the blitheringly idiotic UN) China is still classed as a "developing nation" meaning she doesn’t have to contribute a red cent. China is of course also the world’s largest emitter of greenhouse gases. Couldn’t make it up. Similar hypocrisy and posturing from our friends in Brussels too of course. EU president Ursula von der Leyen couldn’t actually be bothered attending COP29. Not only did this send out a catastrophic “couldn’t care less” message but behind the scenes European delegates were reported to be jockeying to limit the deal to $200bn .... before of course last night celebrating how wonderful they were after the $300bn deal was pushed through largely against their wishes. It surprised precisely no-one that the 27-nation bloc was awarded a Climate Network COP29 award for “doing the most to achieve the least”. Meanwhile France’s pint-pot Napoleon Emmanuel Macron similarly disgraced himself by effectively boycotting the proceedings. And this had nothing to do with climate change and everything to do with keeping the votes of France’s Armenian diaspora who despise Azerbaijan and President Aliyev. German leader Olaf Scholz didn’t bother and Dutch Prime Minister Dick Schoof didn’t think it worth his time either. A number of EU critics suggested so many Euro nations are now so overwhelmed with debt and are taxing citizens into near penury that they thought it best to stay away from Baku rather than admit they are basically broke. And you can see why the Association of Small Island States (brought to the world’s attention by Azerbaijan’s president Ilham Aliyev on day one of the conference incidentally) are less than convinced by the “Global North’s” commitment to tackling climate change. The Maldives are three feet above sea level, the Seychelles, Mauritius and many Caribbean islands not much more. The inhabitants have every right to be very nervous. We will simply lose these islands as a planet unless we pull our collective finger out. Final assessment? Yes COP29 was a fudge, and the politicking would make your flesh crawl, but ultimately a bad deal is better than no deal. For everyone. Even the perpetually apoplectic Greta Thunberg knows this and tweeted as much. So yes, a huge amount of work remains to be done by the COP29 Presidency in the run up to COP30 Rio - especially with the huge elephant in the room that is a Trump presidency. But 196 nations came together and emerged with something. A very imperfect something, but a hell of a lot better than nothing.

BNP Paribas Financial Markets lifted its holdings in shares of Glaukos Co. ( NYSE:GKOS – Free Report ) by 186.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,726 shares of the medical instruments supplier’s stock after acquiring an additional 8,942 shares during the quarter. BNP Paribas Financial Markets’ holdings in Glaukos were worth $1,788,000 as of its most recent filing with the Securities and Exchange Commission. A number of other institutional investors have also recently added to or reduced their stakes in GKOS. EFG Asset Management North America Corp. lifted its stake in shares of Glaukos by 0.5% during the second quarter. EFG Asset Management North America Corp. now owns 27,205 shares of the medical instruments supplier’s stock worth $3,216,000 after purchasing an additional 128 shares in the last quarter. Values First Advisors Inc. acquired a new position in Glaukos during the 3rd quarter worth approximately $25,000. New York State Teachers Retirement System boosted its holdings in Glaukos by 0.4% in the 3rd quarter. New York State Teachers Retirement System now owns 48,143 shares of the medical instruments supplier’s stock worth $6,272,000 after acquiring an additional 200 shares during the period. KBC Group NV grew its position in Glaukos by 16.2% in the third quarter. KBC Group NV now owns 1,445 shares of the medical instruments supplier’s stock valued at $188,000 after acquiring an additional 201 shares in the last quarter. Finally, Inspire Investing LLC raised its stake in shares of Glaukos by 6.9% during the third quarter. Inspire Investing LLC now owns 3,193 shares of the medical instruments supplier’s stock valued at $416,000 after purchasing an additional 206 shares during the period. 99.04% of the stock is owned by hedge funds and other institutional investors. Insider Activity In other Glaukos news, COO Joseph E. Gilliam sold 2,275 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $138.97, for a total transaction of $316,156.75. Following the completion of the transaction, the chief operating officer now directly owns 102,169 shares of the company’s stock, valued at $14,198,425.93. The trade was a 2.18 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink . Also, Director Gilbert H. Kliman sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $130.67, for a total transaction of $392,010.00. Following the completion of the sale, the director now owns 32,336 shares in the company, valued at $4,225,345.12. The trade was a 8.49 % decrease in their position. The disclosure for this sale can be found here . Corporate insiders own 6.40% of the company’s stock. Glaukos Stock Performance Glaukos ( NYSE:GKOS – Get Free Report ) last posted its quarterly earnings results on Monday, November 4th. The medical instruments supplier reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.48) by $0.20. The business had revenue of $96.70 million during the quarter, compared to analyst estimates of $91.50 million. Glaukos had a negative net margin of 42.43% and a negative return on equity of 18.99%. The company’s quarterly revenue was up 23.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.50) EPS. Equities research analysts forecast that Glaukos Co. will post -1.89 EPS for the current year. Wall Street Analyst Weigh In GKOS has been the subject of several analyst reports. Stifel Nicolaus upped their target price on shares of Glaukos from $145.00 to $153.00 and gave the company a “buy” rating in a research note on Monday, December 2nd. UBS Group began coverage on Glaukos in a research note on Friday. They set a “buy” rating and a $182.00 target price for the company. Morgan Stanley cut Glaukos from an “equal weight” rating to an “underweight” rating and set a $120.00 price target on the stock. in a research note on Monday, December 2nd. Piper Sandler set a $140.00 price target on Glaukos in a report on Thursday, October 17th. Finally, StockNews.com upgraded Glaukos from a “sell” rating to a “hold” rating in a report on Monday, October 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Glaukos presently has a consensus rating of “Moderate Buy” and an average price target of $140.00. Check Out Our Latest Analysis on Glaukos Glaukos Profile ( Free Report ) Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. See Also Receive News & Ratings for Glaukos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos and related companies with MarketBeat.com's FREE daily email newsletter .

Andrew Schulz & Kendrick Lamar Beef, Explained

Article content The Raptors got taught a tough lesson by the title-contending Oklahoma City Thunder on Thursday: They aren’t in OKC’s class, not even close, and even if Jakob Poeltl had been able to play, that still would be the case (keep in mind the Thunder was also missing star big man Chet Holmgren). Recommended Videos While no team can enjoy losing by 37 points, it will benefit the players in the long run. As rookie Jonathan Mogbo said post-game, “That was a great team ... We have to learn when we’re ready to catch and shoot, got to shoot it. Teams like that are going to try to force us to shoot, so got to take our time live with the shot, even if it doesn’t go down. Stay consistent and confident.” As head coach Darko Rajakovic put it: “They’re a team that’s built for now. I think there’s a lot from us to look at that team and learn about physicality they play with, how they’re aggressive,” Rajakovic said. “They’re number one in the league in creating turnovers. And that’s very interesting for us, sometimes we turn it over recklessly, and sometimes it’s because of the other defence. I felt tonight it was the other defence that made us turn the ball over. So there’s going to be a lot of good for us to go through this.” Toronto was coming off some nice performances, but a reality check like that will beneficial in helping the team recognize how to improve and that they are a long way from actually competing with good NBA teams. Toronto is just 3-11against teams .500 or better, vs. 4-5 against weaker opponents. It hasn’t helped that Toronto has yet to field its full starting lineup this season and has only had four of the starters (Scottie Barnes, Immanuel Quickley, Poeltl, RJ Barrett and Gradey Dick) available on the same night in six of 23 games (with key veteran backups Kelly Olynyk and Bruce Brown yet to play at all). More takeaways and a look ahead to a second straight Toronto visit by an NBA MVP candidate, this time Dallas star Luka Doncic: ONE OF A KIND It says something about how brilliant Shai Gilgeous-Alexander is that he can shoot 1-for-10 on three-point attempts and still look dominant. The Raptors tried a number of ways to slow him, but only Ochai Agbaji had much success. Davion Mitchell had bothered star point guards like De’Aaron Fox, Tyrese Haliburton, LaMelo Ball and Darius Garland quite a bit this season, but Gilgeous-Alexander shrugged him off. It was a hope he misses long shots kind of night, but even that wasn’t enough. I talked to Kelly Olynyk pre-game about his Canadian national team pal Gilgeous-Alexander and how he’s added increased outside shooting to the arsenal (he’s taking over six a game now vs. 2.5 and 3.1 the previous two seasons). Olynyk saw it as a way for Gilgeous-Alexander to make himself less predictable and even harder to stop. “You have to guard him for that now, as he continues to develop that makes that a shot that he’s comfortable with, and going to you’re gonna have to press up and make sure to take some of that stuff away,” Olynyk said. “Or is that something you’re living with? Because he does everything else at a such an elite level ... He’s going to look at how people are guarding him and doing stuff, and he’s going to figure out how he can counter that. And I think shooting that the threes and the pound dribble, step-back and walk up threes, because guys are maybe, they’re scared. They’re scared of what he can do with the ball. So yeah, he’s gonna keep adding stuff to his game and keep making sure he’s as dynamic as he can be.” MOGBO IN THE MIDDLE Without Poeltl and Olynyk (who were both upgraded to questionable for Saturday against Dallas) Rajakovic decided to start Bruno Fernando. Things went downhill after Fernando won the opening tip, with the reserve big man picking up turnovers and fouls before being subbed out (he fared better in a couple of stints later in the game). Rajakovic opted to start Jonathan Mogbo in the third quarter and the rookie again showed flashes, despite being a team-worst -28 against the loaded Thunder. Mogbo scored a career-high 17 points in 23 minutes, and though he didn’t rebound like he usually does (grabbing only one, along with an assist, steal and block), the 31st pick of the 2024 draft is having a nice start to his career. “It was really good for me tonight to see Jonathan Mogbo in an expanding role, against different matchups,” Rajakovic said after first noting how much the team misses Poeltl. “I thought that he had overall good game tonight.” Mogbo actually played a double-header, joining some teammates to also suit up for Raptors 905 earlier in the day before also playing with the Raptors. “Today was different, kind of felt like AAU back in the day, just go out, play hard. Kids were out there (in the crowd), had great energy this morning so that’s what Its all about,” Mogbo said. @WolstatSun

Tidal Investments LLC raised its position in Fabrinet ( NYSE:FN – Free Report ) by 46.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,089 shares of the technology company’s stock after acquiring an additional 978 shares during the quarter. Tidal Investments LLC’s holdings in Fabrinet were worth $730,000 at the end of the most recent quarter. Several other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP grew its position in shares of Fabrinet by 1.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,169,162 shares of the technology company’s stock valued at $276,437,000 after acquiring an additional 19,677 shares during the period. Geode Capital Management LLC lifted its position in Fabrinet by 7.6% during the third quarter. Geode Capital Management LLC now owns 986,813 shares of the technology company’s stock valued at $233,359,000 after purchasing an additional 69,554 shares in the last quarter. Whale Rock Capital Management LLC increased its position in Fabrinet by 25.8% in the third quarter. Whale Rock Capital Management LLC now owns 855,767 shares of the technology company’s stock worth $202,338,000 after buying an additional 175,684 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Fabrinet by 14.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 480,550 shares of the technology company’s stock worth $113,621,000 after buying an additional 61,491 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in shares of Fabrinet by 4.1% in the second quarter. Bank of New York Mellon Corp now owns 314,665 shares of the technology company’s stock worth $77,027,000 after buying an additional 12,409 shares during the period. 97.38% of the stock is owned by hedge funds and other institutional investors. Fabrinet Stock Performance FN stock opened at $221.26 on Friday. The company’s fifty day moving average price is $242.77 and its 200-day moving average price is $237.78. Fabrinet has a one year low of $159.69 and a one year high of $278.38. The company has a market capitalization of $8.02 billion, a PE ratio of 26.18 and a beta of 0.92. Wall Street Analyst Weigh In FN has been the subject of several analyst reports. Barclays started coverage on shares of Fabrinet in a report on Thursday, November 14th. They issued an “equal weight” rating and a $292.00 target price for the company. B. Riley downgraded shares of Fabrinet from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $194.00 to $178.00 in a research report on Wednesday, November 20th. Finally, Needham & Company LLC started coverage on shares of Fabrinet in a report on Tuesday, November 5th. They issued a “buy” rating and a $280.00 target price for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $252.14. Check Out Our Latest Stock Analysis on FN Fabrinet Company Profile ( Free Report ) Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing. See Also Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet ( NYSE:FN – Free Report ). Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter .As the final seconds came off the clock last Friday night at Canvas Stadium and the Colorado State football team rushed across the field to get their hands on the Bronze Boot, it was only fitting that the longest tenured Ram, Dane Olson, got his hands on it first. Most Popular Trending Nationally

Army of civilian experts needed to guard nation’s interests: SC judge

Previous: super ufa slot jili download

Next: slot super ace jili games gameplay